Breaking News Instant updates and real-time market news.

FOLD

Amicus

$15.36

0.26 (1.72%)

13:10
08/10/18
08/10
13:10
08/10/18
13:10

Amicus halted ahead of PDUFA date for Migalastat HCI

Amicus Therapeutics previously announced in February that the FDA had accepted the New Drug Application for filing under priority review for the oral precision medicine migalastat HCl for the treatment of patients 16 years and older with Fabry disease who have amenable mutations. The Prescription Drug User Fee Act, or PDUFA, goal date for the FDA decision is August 13.

  • 13

    Aug

  • 25

    Aug

  • 12

    Sep

FOLD Amicus
$15.36

0.26 (1.72%)

09/15/17
JPMS
09/15/17
NO CHANGE
Target $15
JPMS
Overweight
JPMorgan continues to see upside in Amicus shares
JPMorgan analyst Anupam Rama says Amicus Therapeutics remains one of his top picks, and that he continues to see upside from current share levels, ahead of the upcoming Pompe data readout. The analyst sees a high probability that the Q3 data update will meet or exceed the efficacy benchmarks, leading to increased probability of success/revenue estimates across Street models. His base case, with a 75% probability of success assumption, still provides for 10%-15% upside from current share levels. His "homerun scenario," which is maintaining the 6MWD benefit shown in Q2 or better, has the stock rallying 35%-40%.
10/04/17
BOFA
10/04/17
NO CHANGE
Target $20
BOFA
Buy
Amicus price target raised to $20 from $15 at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad raised Amicus' price target to $20 from $15 saying the Phase 1/2 trial results of ATB200/AT2221 in Pompe disease were impressive. The analyst thinks the strong data justifies progression into pivotal trials and may result in an accelerated approval path. Ahmad rates Amicus a Buy.
04/11/18
JPMS
04/11/18
NO CHANGE
JPMS
Overweight
Amicus risk/reward favorable into regulatory update, says JPMorgan
JPMorgan analyst Anupam Rama notes that a regulatory update for Amicus Therapeutics' Pompe program is expected in Q2. The analyst continues to like the reward/risk profile of the shares going into the update. An accelerated approval path forward is "very much on the table," based on the strength of the Phase 1/2 data, Rama tells investors in a research note. He sees "more win scenarios than lose." The analyst believes Amicus shares can rally 30%-50% should an accelerated approval path forward emerge. Rama keeps an Overweight rating on Amicus with a $19 price target.
05/08/18
JPMS
05/08/18
NO CHANGE
JPMS
Amicus lower on Pompe program commentary, says JPMorgan
JPMorgan analyst Anupam Rama attributes today's post-earnings weakness in shares of Amicus Therapeutics to "conservative commentary" on the call related to the Pompe program. The analyst, however, does not believe that the regulatory scenarios he outlined last month for the program have fundamentally changed. Nonetheless, Rama thinks commentary on the call, particularly on timing, was perceived as cautious. Amicus shares are down 7.5% to $13.49 in midday trading.

TODAY'S FREE FLY STORIES

PENN

Penn National

$31.77

0.71 (2.29%)

10:33
08/16/18
08/16
10:33
08/16/18
10:33
Hot Stocks
Penn National announces launch dates for sports betting at Mississippi casinos »

Penn National Gaming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
08/16/18
08/16
10:30
08/16/18
10:30
General news
EIA natural gas storage change for week ending August 10 »

Gas inventories 33 Bcf…

CTL

CenturyLink

$22.96

0.48 (2.14%)

10:30
08/16/18
08/16
10:30
08/16/18
10:30
Options
Sweep buyer of CenturyLink in the money puts as shares reach 52-week highs »

Sweep buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBNY

Signature Bank

$114.29

1.53 (1.36%)

10:29
08/16/18
08/16
10:29
08/16/18
10:29
Hot Stocks
Signature Bank announces special meeting to approve stock buyback program »

Signature Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 29

    Oct

10:20
08/16/18
08/16
10:20
08/16/18
10:20
General news
Market opens sharply higher on renewed trade hopes »

Stock futures were…

ROK

Rockwell Automation

$172.79

1.13 (0.66%)

10:20
08/16/18
08/16
10:20
08/16/18
10:20
Options
Call buyer in Rockwell as shares see strength »

Call buyer in Rockwell as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/16/18
08/16
10:17
08/16/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$122.72

0.03 (0.02%)

10:16
08/16/18
08/16
10:16
08/16/18
10:16
Hot Stocks
KFx Medical, Zimmer Biomet enter into license agreement »

KFx Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/16/18
08/16
10:16
08/16/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/16/18
08/16
10:15
08/16/18
10:15
General news
Breaking General news story  »

Week of 8/10 EIA Natural…

POST

Post Holdings

$96.51

1.73 (1.83%)

, SYK

Stryker

$168.57

1.735 (1.04%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

POST

Post Holdings

$96.51

1.73 (1.83%)

SYK

Stryker

$168.57

1.735 (1.04%)

AVEO

Aveo Pharmaceuticals

$2.26

0.085 (3.91%)

UXIN

Uxin

$5.58

0.315 (5.98%)

ACRX

AcelRx

$2.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 22

    Aug

  • 23

    Aug

  • 04

    Sep

  • 12

    Sep

AZN

AstraZeneca

$38.35

-0.1 (-0.26%)

, CX

Cemex

$6.80

0.005 (0.07%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

AZN

AstraZeneca

$38.35

-0.1 (-0.26%)

CX

Cemex

$6.80

0.005 (0.07%)

CVE

Cenovus Energy

$8.97

0.015 (0.17%)

NANO

Nanometrics

$41.46

-3.74 (-8.27%)

COTY

Coty

$11.37

-0.06 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 21

    Aug

  • 25

    Aug

  • 28

    Aug

  • 09

    Oct

LULU

Lululemon

$127.75

1.27 (1.00%)

, KMB

Kimberly-Clark

$117.47

1 (0.86%)

10:12
08/16/18
08/16
10:12
08/16/18
10:12
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

LULU

Lululemon

$127.75

1.27 (1.00%)

KMB

Kimberly-Clark

$117.47

1 (0.86%)

ERJ

Embraer

$19.49

0.855 (4.59%)

FTI

TechnipFMC

$28.19

0.59 (2.14%)

AVLR

Avalara

$37.90

3.22 (9.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 30

    Aug

  • 12

    Sep

RADA

RADA Electronic

$2.55

0.01 (0.39%)

10:10
08/16/18
08/16
10:10
08/16/18
10:10
Initiation
RADA Electronic initiated  »

RADA Electronic initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$43.82

0.35 (0.81%)

10:10
08/16/18
08/16
10:10
08/16/18
10:10
Options
Another utility name with one day call buying »

Another utility name with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$127.16

0.68 (0.54%)

, KMB

Kimberly-Clark

$117.91

1.44 (1.24%)

10:06
08/16/18
08/16
10:06
08/16/18
10:06
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

LULU

Lululemon

$127.16

0.68 (0.54%)

KMB

Kimberly-Clark

$117.91

1.44 (1.24%)

COTY

Coty

$11.34

-0.09 (-0.79%)

ATVI

Activision Blizzard

$69.47

0.2 (0.29%)

NKE

Nike

$80.12

0.56 (0.70%)

UA

Under Armour

$19.22

0.19 (1.00%)

UAA

Under Armour

$20.79

0.2 (0.97%)

VFC

VF Corp.

$92.13

-0.17 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 30

    Aug

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

C

Citi

$69.49

0.85 (1.24%)

, CAT

Caterpillar

$134.50

2.49 (1.89%)

10:03
08/16/18
08/16
10:03
08/16/18
10:03
Hot Stocks
Citi Retail Services announces long-term agreement with Caterpillar Financial »

Citi Retail Services (C)…

C

Citi

$69.49

0.85 (1.24%)

CAT

Caterpillar

$134.50

2.49 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

GTN

Gray Television

$16.40

-0.05 (-0.30%)

, CBS

CBS

$52.89

0.09 (0.17%)

10:02
08/16/18
08/16
10:02
08/16/18
10:02
Hot Stocks
Gray Television to sell WSWG-TV in Albany, Georgia »

Gray Television (GTN)…

GTN

Gray Television

$16.40

-0.05 (-0.30%)

CBS

CBS

$52.89

0.09 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 27

    Sep

GM

General Motors

$36.49

0.55 (1.53%)

, RDS.A

Royal Dutch Shell

$63.18

0.95 (1.53%)

10:02
08/16/18
08/16
10:02
08/16/18
10:02
Hot Stocks
GM, Shell deliver nationwide in-dash fuel payment »

Shell Oil Company (RDS.A)…

GM

General Motors

$36.49

0.55 (1.53%)

RDS.A

Royal Dutch Shell

$63.18

0.95 (1.53%)

RDS.B

Royal Dutch Shell

$65.20

0.92 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$9.12

-0.63 (-6.46%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF falls -6.6% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNL

Global Net Lease

$20.61

-1.47 (-6.66%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Global Net Lease falls -6.6% »

Global Net Lease is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

DDS

Dillard's

$74.93

-8.05 (-9.70%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Dillard's falls -9.8% »

Dillard's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATV

Acorn International

$17.84

(0.00%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
Acorn International rises 10.1% »

Acorn International is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$128.36

0.3 (0.23%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Options
Electronic Arts with repeat option action late yesterday »

Electronic Arts with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

WUBA

58.com

$65.22

6.63 (11.32%)

10:00
08/16/18
08/16
10:00
08/16/18
10:00
Hot Stocks
58.com rises 11.2% »

58.com is up 11.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 10

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.